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Background: Clostridium butyricum is a butyric acid-producing anaerobic bacteriuma, and commonly present as
gut microbiota in humans. This species has been used as a probiotic for the prevention of diarrhea in humans. In
this study, we report the draft genome of C. butyricum DKU-01, which was isolated from infant feces, to better
understand the characteristics of this strain so that it can later be used in the development of probiotic products.
Results: A total of 79 contigs generated by hybrid assembly of sequences obtained from Roche 454 and Illumina
Miseq sequencing systems were investigated. The assembled genome of strain DKU-01 consisted of 4,519,722 bp
(28.62% G + C content) with a N50 contig length of 108,221 bp and 4,037 predicted CDSs. The extracted 16S rRNA
gene from genome sequences of DKU-01 was similar to Clostridium butyricum with 99.63% pairwise similarity. The
sequence of strain DKU-01 was compared with previously reported genome sequences of C. butyricum. The value
of average nucleotide identity between strains DKU-01 and C. butyricum 60E3 was 98.74%, making it the most
similar strain to DKU-01.
Conclusions: We sequenced the DKU-01 strain isolated from infant feces, and compared it with the available
genomes of C. butyricum on a public database. Genes related to Fructooligosaccharide utilization were detected in
the genome of strain DKU-01 and compared with other genera, such as Bifidobacterium and Streptococcus. We
found that strain DKU-01 can metabolize a wide range of carbohydrates in comparative genome result. Further
analyses of the comparative genome and fermentation study can provide the information necessary for the
development of strain DKU-01 for probiotics.
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The intestinal tract harbors various microbes that play a
key role in the nutrition, health, and physiology of the
host. Probiotic bacteria have been defined as live micro-
organisms, when administered in sufficient amounts,
which give a health benefit on the host organisms. In
practice, probiotics can improve the balance of the intes-
tinal microbiota ecosystem of the host, which is benefi-
cial in treating variety of infant conditions including,
infant diarrhea, upset stomach, eczema, and many health
conditions of pre-term infants. It is also an effective alter-
native to antibiotics for growth promotion in a diverse* Correspondence: choh@dankook.ac.kr
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unless otherwise stated.number of livestock species [1]. In addition, it is reported
that various immune responses are influenced by probio-
tics and these immunomodulatory effects have been pro-
posed for use in several potential applications, including
management of hypersensitivity reactions, prevention of
infectious diarrhea, and tumor suppression [2]. A number
of scientific progressions have led to the current situation,
in which many probiotic strains exist and are in widespread
use. For example, Lactobacillus delbrueckii subsp bulgari-
cus, Lactobacillus acidophilus, Lactobacillus rhamnosus,
Bifidobacterium bifidum, Bifidobacterium adolescentis,
Bifidobacterium infantis, Streptococcus thermophilus,
Enterococcus faecalis, and Enterococcus faecium are cur-
rently being used in probiotic preparations either singly
or in combination [3].
Clostridium butyricum is a butyric acid-producing
gram-positive anaerobe which is found in soil and the
intestines of healthy animals and humans, and the strains is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Mo et al. Gut Pathogens  (2015) 7:8 Page 2 of 7MIYAIRI 588 of C. butyricum has been used as a pro-
biotic in Asia for treating and preventing non-
antimicrobial induced diarrhea, antimicrobial-associated
diarrhea, and constipation in humans [4,5]. In addition,
C. butyricum produces short chain fatty acids (SCFAs),
such as butyric acid, propionic acid, and acetic acid. Sev-
eral reports have suggested that SCFAs have potential
beneficial effects; in particular, butyric acid has a prolif-
erative effect on intestinal mucosal cells [6] and anti-
inflammatory effects [7]. Moreover, C. butyricum can
ferment sugar and glycerol to several biofuels and pre-
cursors of biomaterials, such as H2, butanol, butyric
acid, and 1,3-propanediol [8-11]. Due to the exhaustion
of fossil fuels, the conversion of renewable biomass to
valuable fuels and chemicals by microorganisms has
drawn global interest [12]. For this reason, C. butyricum
is receiving renewed attention, and it is very important
to isolate the stain. Therefore, investigation of the gen-
etic information and characteristics of C. butyricum
DKU-01 is desired. The genome sequence analysis has
been proven very useful information for understanding
of C. butyricum DKU-01, which exhibits unique physio-




Fecal samples were collected from breast-feeding infants
less than three months old at a hospital and postpartum
care center in nearby Cheonan-Asan from 2012 to 2013.
None of the infants had received antibiotics or other
drugs in the months prior to sampling. Fecal samples (1
g) were collected on sterilized cotton-tipped swabs and
these swabs were placed in sterile 15 ml conical tubes
containing 5 ml of GYP liquid medium overlaying the
top of the medium with liquid paraffin. These tubes were
transferred to GasPak anaerobic jars (Becton, Dickinson
and Company, NJ, USA) for further study within 30 min
of the collection.
Isolation and identification of strain
For the isolation of C. butyricum from infant feces, col-
lected fecal samples were incubated at 30°C in an anaer-
obic chamber (Forma Anaerobic System; Thermo Fisher
Scientific Inc., Waltham, MA, USA) using a gas phase of
N2/H2/CO2 (80:10:10%, v/v) for 3 days. After enrich-
ment, they were further serially diluted and plated on
RCM (Reinforced Clostridial Medium, BD) for anaerobes
in an anaerobic chamber at 30°C for 48 h. Morphologic-
ally different colonies were selected randomly. The se-
lected colonies were purified by repeated streaking on
the agar media and subcultured periodically.
All isolated strains used in this work were tested for
catalase. Single colonies were selected and grown inRCM broth in order to establish pure cultures of the gas
bubble-producing strains. One hundred and two isolates
showing a bubble with soap skin were selected as the
candidates and their biochemical profiles were con-
firmed using API 20A (BioMerieux, Basingstoke, UK) in
order to identify the isolates. One strain, DKU-01, which
showed the active formation of gas bubbles, was chosen
for further studies and its identification was confirmed
by 16S rRNA sequencing.
For the identification of 16S rRNA sequences, genomic
DNA was extracted from the strain using the phenol extrac-
tion method. The 16S rRNA gene was amplified using a
polymerase chain reaction (PCR) with the universal primers
27F (5′-AGAGTTTGATCMTGGCTCAG-3′) and 1492R
(5′-TACGGTYACCTTGTTGTTACGACTT-3′). The con-
ditions of amplification were: 94°C for 5 min denaturation,
followed by 30 cycles at 94°C for 1 min, 50°C for 1 min,
and 72°C for 1 min and 50 sec, with a final 4 min
extension at 72°C. After amplification, the PCR prod-
ucts were purified using an AccuPrep PCR purification
kit (BIONEER, Daejeon, Korea) and sequenced with the
ABI prism™ Bigdye™ Terminator Cycle sequencing ready
reaction kit in an automated ABI 3730XL capillary DNA
sequencer (Applied Biosystems, Foster City, CA, USA).
Strain DKU-01 was identified as Clostridium butyricum
and was deposited in the strain collection of the Korean
Culture Center of Microorganisms (Daejeon, Korea)
under accession number KCTC 12367BP.
Genome sequencing for strain DKU-01
The extracted genomic DNA was confirmed by 1% agar-
ose gel electrophoresis and visualized under a Gel Doc
system (Bio-Rad, Hercules, CA, USA) and the concen-
tration of DNA was quantified using a PicoGreen
dsDNA Assay Kit (Invitrogen, Carlsbad, CA, USA).
To verify contamination of DNA or isolate culture,
16S rRNA gene (about 1.4kb) was amplified and
sequenced again. After confirmation of the isolated
DNA, a sequencing library for the Illumina machine
was prepared using Truseq DNA LT Sample Prep
Kit (Illumina, San Diego, CA, USA) and a library for
the Roche 454 machine was constructed using the
GS FLX Titanium Rapid Library Preparation Kit (454
Life Science, Branford, CT, USA). The genome se-
quencing of strain DKU-01 was performed by the
Illumina Miseq (250 bp paired end sequencing) and
Roche 454 (8Kb-insert paired end sequencing) se-
quencing systems.
Assembly and annotation of genome sequence
The de novo assembly was conducted using the CLC
genomic workbench 6.0 (CLC Bio, Denmark) with se-
quences obtained from the Miseq system and the GS
Assembler 2.6 (Roche Diagnostics, Branford, CT, USA)
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sembly of generating contigs from both systems was per-
formed using the CodonCode Aligner (CodonCode Co.
Dedham, MA, USA). Gene prediction was performed using
Glimmer 3 [13], and the annotations were conducted by a
homology search against Clusters of Orthologous Groups
(COG) and the SEED database [14,15]. The comparative
analyses of gene contents were performed using the RAST
server [16]. The chromosomal region focusing fructooli-
gosaccharide utilization in contig number 22 of strain
DKU-01 was compared with synteny in similar organism
using browse genome on the RAST server. The nucleotide
similarities of msm operon were obtained by webcat
(www.webact.org/WebACT/home) using BLASTN.
Quality assurance
The potential contamination was confirmed by identifi-
cation of 16S rRNA gene and comparison of the genome
sequence with the published genomes of the same genus.
16S rRNA genes were extracted from assembled contigs
using the rRNA selector [17] and identified by using the
EzTaxon-e database (http://eztaxon-e.ezbiocloud.net) [18].
Genome sequences were compared with available ge-
nomes of Clostridium spp. on the NCBI database using
the average nucleotide identity (ANI) values [19]. The
genomic distance between genome sequences were cal-
culated using ANI values. In a pair of genomes, the
query sequence was cut into small fragments (1020bp).
Then, high-scoring segment pairs between genomes
were determined by the BLAST algorithm [19]. For gen-
ome tree, the calculated ANI values were converted into
distances between genomes of Clostridium. The dis-
tance values were obtained from ANI values comple-
ment to 1. This pairwise distance matrix was used to
construct a dendrogram by the Unweighted Pair Group
Method with Arithmetic Mean clustering method. The
digital DNA-DNA hybridization values were calculated




A total of 79 contigs were generated by a hybrid assem-
bly of reads from the Illumina Miseq (12,127,925 reads
of 250bp paired end; ˃554-fold coverage) and Roche 454
(319,439 reads of 8kb-insert paired end; ˃13-fold cover-
age) systems. The genome size of strain DKU-01 was
4,519,722 bases with 28.62% G + C content and 4,037
predicted CDSs, and 59 tRNA and 17 rRNA operons.
The length of the largest contig was 334,920 bp, and the
N50 contig was 108,221 bp. The distributions of COG
and SEED subsystems of strain DKU-01 are depicted in
Figure 1. Among the COG category, R (general function
prediction only; 399 ORFs) and G (carbohydrate transportand metabolism; 313 ORFs) were abundant, followed by
the E category (amino acid transport and metabolism;
288 ORFs), S category (function unknown; 268 ORFs)
and K category (transcription; 251 ORFs). In the subsys-
tem distribution, the subsystems of carbohydrates (454
ORFs) and amino acids and derivatives (385 ORFs) were
well-represented. The subsystems of di- and oligosac-
charides (127 ORFs) and central carbohydrate metabol-
ism (91 ORFs) were prominently detected within the
carbohydrate subsystem. Beta-glucoside metabolism (40
ORFs), maltose and maltodextrin utilization (38 ORFs),
lactose and galactose uptake and utilization (22 ORFs),
and fructooligosaccharides and raffinose utilization (15
ORFs) were abundant categories within the subsystem of
di- and oligosaccharides. Pentose phosphate pathway (20
ORFs), glycolysis and gluconeogenesis (16 ORFs), and the
entner-Doudoroff pathway (13 ORFs) were prominently
detected within the central carbohydrate metabolism
subsystem.
Comparative analysis of DKU-01 genome with genomes
of neighbor strains
Extracted 16S rRNA gene of strain DKU-01 had the high-
est pairwise similarity with Clostridium butyricum DSM
10702T (99.63%). The genome tree of strain DKU-01 was
generated by the ANI values of C. butyricum genomes,
which are available on a public database (Figure 2). The
results of 16S rRNA gene identification and genome tree
indicated that the genome sequences of strain DKU-01
was free of contaminations. Six genome sequences of C.
butyricum were compared with the genome sequences
of DKU-01, and two strains of C. butyricum, 60E3 and
DSM 10702T, were clustered with strain DKU-01. The
ANI value of strain DKU-01 to 60E3 was 98.74% and to
DSM 10702T was 98.73%. The estimated DNA-DNA
hybridization values of strain DHU-01 to 60E3 (90.9 ±
2%) and to DSM 10702T (90.3 ± 2.08%) were obtained
by the GGDC. The genomic features and subsystem distri-
butions were compared among three strains (Additional
file 1: Table S1). The lowest number of contigs was ob-
tained from strain 60E3 (10), while the highest number of
contigs was obtained from strain DSM 10702T (207). The
abundances of gene contents in the subsystems were simi-
lar in all three genomes.
We focused on fructooligosaccharide (FOS) utilization
within the carbohydrate subsystem, because fructooligo-
saccharide has been used as a prebiotic in food products
and infant formulas [20]. FOS can be a derivative of sim-
ple fructose polymers of fructose moieties attached to a
sucrose molecule, and it can be degraded by a variety of
lactic acid bacteria in the gut [21,22]. Lactobacillus acid-
ophilus and Bifidobacterium spp. have been studied for
the utilization of FOS [22,23], and the utilization of FOS
by Clostridium spp. has also been reported [24]. Ten
Figure 1 Statistics of annotated genes for Clostridium butyricum DKU-01 based on COG (A) and SEED (B) databases.
Figure 2 Genome tree of strain DKU-01 with Clostridium butyricum strains obtained from NCBI database.
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Table 1 Summary of ORFs annotated to Fructooligosaccharide utilization
Contig number Length (bp) Gene Seed function
10 1,287 MsmE Multiple sugar ABC transporter, substrate-binding protein
12 1,416 GtfA Sucrose phosphorylase (EC 2.4.1.7)
12 870 MsmR MSM (multiple sugar metabolism) operon regulatory protein
22 1,194 MsmE Multiple sugar ABC transporter, substrate-binding protein
22 864 MsmF Multiple sugar ABC transporter, membrane-spanning permease protein MsmF
22 867 MsmG Multiple sugar ABC transporter, membrane-spanning permease protein MsmG
36 1,110 MsmK Multiple sugar ABC transporter, ATP-binding protein
36 918 MsmR MSM (multiple sugar metabolism) operon regulatory protein
65 1,113 MsmK Multiple sugar ABC transporter, ATP-binding protein
65 906 MsmF Multiple sugar ABC transporter, membrane-spanning permease protein MsmF
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to genes related to FOS utilization (Table 1). The
chromosomal region including MsmE, MsmF, and
MsmG in contig number 22 of strain DKU-01 was com-
pared with synteny in C. botulinum E3, C. beijerincki
NCIMB 8052, Bifidobacterium longum NCC 2705,
B. animalis subsp. lactis AD011, B. adolescentis ATCC
15703, Streptococcus pneumoniae TIGR 4, and S. mutans
UA159 (Figure 3). Functional analysis of the FOS gene
cluster indicated that the ingestion of an oligosaccharide
was interceded by an ATP-dependent binding cassette
(ABC)-type transport system. Genes encoding the ABCFigure 3 Comparison of the msm cluster in contig number 22 of DKU
server). The red arrow (number 1) indicates MsmE; yellow-green arrow (nu
Oligo-1,6-glucosidase; yellow arrow (number 5) Alpha-galactosidase; blue-g
possible NagC/XylR-type transcriptional regulator; green arrow (number 8) t
probable NhaP-type Na(+)/H(+) exchanger; sky-blue arrow (number 10) Suc
regulatory protein; pistachio arrow (number 12) Threonine dehydratase; lim
(number 14) NAD-dependent protein deacetylase of SIR2 family; primrose a
in the figure are sets of genes with similar sequences. Genes whose relative p
and shared gray background boxes.transport system (MsmEFGK) as well as a putative intra-
cellular fructosidase (bfrA) were found to be located in a
multiple-sugar metabolism (msm) operon. Although the
gene contents surrounding MsmE, MsmF, and MsmG
were different between genera, the Msm cluster revealed
a high degree of synteny. The divergence of msm operon
sequences were analyzed by artemis comparison at nu-
cleotide level. This highest nucleotide similarity value
was investigated in MsmF gene from DKU-01 to
C. botulinum E3 (85%). The similarity value of msm op-
eron nucleotides from DKU-01 to C. botulinum E3 was
81.6%, and to C. beijerincki NCIMB 8052 was 68%. The-01 genome with selected bacteria (based on RAST annotation
mber 2) MsmF; brown arrow (number 3) MsmG; blue arrow (number 4)
reen (number 6) Catabolite control protein A; pink arrow (number 7)
RNA-specific adenosine-34 deaminase; dark brown arrow (number 9)
rose phosphorylase; dark-gray arrow (number 11) MSM operon
e-green arrow (number 13) Aldehyde dehydrogenase B; purple arrow
rrow (number 15) possible phospholipase. The same number and color
osition is conserved in at least four other species are functionally coupled
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ranged from 45.18% to 65%. The general structure of the
identified gene clusters encoding upregulated genes in-
volved in carbohydrate ingestion and catabolism indi-
cates that typically, a three component system consisting
of a regulator, transporter, and glycoside hydrolase(s) can
be sufficient for utilization of potential prebiotics, irrespect-
ive of the type of transporter identified (phosphoenolpyr-
uvate-dependent sugar phosphotransferase systems (PTS),
galactoside pentose hexuronide (GPH) permease, and
ABC-type transporters). Most notably, PTS permeases
had higher selectivity towards disaccharides e.g. sucrose,
lactose, and maltose, whereas ABC and GPH permeases
showed to be induced by the longer oligosaccharides e.g.
stachyose and β-galactooligosaccharides. Furthermore,
similar upregulation patterns of gene expression by widely
different prebiotics was interesting, remarkably the FOS-
ABC transporter that was also induced by the mixed link-
age polydextrose. This suggests that transporters either
possess more than one specificity or less stringent mo-
lecular recognition of substrates, indicating that a wide
range of carbohydrates can be metabolized by C. butyri-
cum DKU-01, and likely similar commensal and probiotic
bacteria.Future directions
Further analyses of the genome comparisons and FOS fer-
mentation will provide greater information to improve the
probiotic effects of strain DKU-01. This information can
help to develop improved probiotics for public health.Availability of supporting data
The obtained genome sequence of Clostridium butyricum
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